Review





Similar Products

94
Bio-Rad monoclonal anti plp
Monoclonal Anti Plp, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proteolipid+protein+plp/Mouse+anti+Myelin+Proteolipid+Protein/pm41376199-137-42-46
Average 94 stars, based on 1 article reviews
monoclonal anti plp - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

99
Bio-Rad myelin proteolipid protein plp staining
Neuropathological findings across study subjects. (A) Staining with AT8 (Tau) across superior and middle temporal samples from each study subject (left panel). (B) Higher magnification AT8 staining (right panel) from representative grey and white matter regions, indicated by squares in the left panel. (C) Immunohistochemical staining with TDP-43 across the preparations from all study subjects (left panel). (D) Corresponding magnification of grey and white matter regions (right panel), indicated by squares in the left panel. (E) Additional magnification and morphological features of TDP-43 aggregates in GM regions from FTLD subjects. Additional whole-section and high magnification images of grey and white matter stained for β-amyloid (F) and <t>proteolipid</t> protein <t>(PLP)</t> (G) are presented for each frontotemporal lobar dementia case. FTLD, frontotemporal lobar dementia; H-AD, high likelihood Alzheimer’s disease; AT8, phosphorylated tau protein; He, hematoxylin; GM, grey matter; WM, white matter; TDP-43, TAR DNA-binding protein 43; PLP, proteolipid protein. NIIs, intranuclear inclusion; NCIs, neuronal cytoplasmic inclusions; DNs, dystrophic neurites.
Myelin Proteolipid Protein Plp Staining, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proteolipid+protein+plp/Protein+Standard+I/pmc12711859-63-0-5
Average 99 stars, based on 1 article reviews
myelin proteolipid protein plp staining - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

94
Bio-Rad anti plp antibodies
Neuropathological findings across study subjects. (A) Staining with AT8 (Tau) across superior and middle temporal samples from each study subject (left panel). (B) Higher magnification AT8 staining (right panel) from representative grey and white matter regions, indicated by squares in the left panel. (C) Immunohistochemical staining with TDP-43 across the preparations from all study subjects (left panel). (D) Corresponding magnification of grey and white matter regions (right panel), indicated by squares in the left panel. (E) Additional magnification and morphological features of TDP-43 aggregates in GM regions from FTLD subjects. Additional whole-section and high magnification images of grey and white matter stained for β-amyloid (F) and <t>proteolipid</t> protein <t>(PLP)</t> (G) are presented for each frontotemporal lobar dementia case. FTLD, frontotemporal lobar dementia; H-AD, high likelihood Alzheimer’s disease; AT8, phosphorylated tau protein; He, hematoxylin; GM, grey matter; WM, white matter; TDP-43, TAR DNA-binding protein 43; PLP, proteolipid protein. NIIs, intranuclear inclusion; NCIs, neuronal cytoplasmic inclusions; DNs, dystrophic neurites.
Anti Plp Antibodies, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proteolipid+protein+plp/Mouse+anti+Myelin+Proteolipid+Protein/pm40643490-114-15-18
Average 94 stars, based on 1 article reviews
anti plp antibodies - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Bio-Rad myelin plp
Neuropathological findings across study subjects. (A) Staining with AT8 (Tau) across superior and middle temporal samples from each study subject (left panel). (B) Higher magnification AT8 staining (right panel) from representative grey and white matter regions, indicated by squares in the left panel. (C) Immunohistochemical staining with TDP-43 across the preparations from all study subjects (left panel). (D) Corresponding magnification of grey and white matter regions (right panel), indicated by squares in the left panel. (E) Additional magnification and morphological features of TDP-43 aggregates in GM regions from FTLD subjects. Additional whole-section and high magnification images of grey and white matter stained for β-amyloid (F) and <t>proteolipid</t> protein <t>(PLP)</t> (G) are presented for each frontotemporal lobar dementia case. FTLD, frontotemporal lobar dementia; H-AD, high likelihood Alzheimer’s disease; AT8, phosphorylated tau protein; He, hematoxylin; GM, grey matter; WM, white matter; TDP-43, TAR DNA-binding protein 43; PLP, proteolipid protein. NIIs, intranuclear inclusion; NCIs, neuronal cytoplasmic inclusions; DNs, dystrophic neurites.
Myelin Plp, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proteolipid+protein+plp/Mouse+anti+Myelin+Proteolipid+Protein/pmc12395420-644-0-3
Average 94 stars, based on 1 article reviews
myelin plp - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Bio-Rad mouse anti plp
Neuropathological findings across study subjects. (A) Staining with AT8 (Tau) across superior and middle temporal samples from each study subject (left panel). (B) Higher magnification AT8 staining (right panel) from representative grey and white matter regions, indicated by squares in the left panel. (C) Immunohistochemical staining with TDP-43 across the preparations from all study subjects (left panel). (D) Corresponding magnification of grey and white matter regions (right panel), indicated by squares in the left panel. (E) Additional magnification and morphological features of TDP-43 aggregates in GM regions from FTLD subjects. Additional whole-section and high magnification images of grey and white matter stained for β-amyloid (F) and <t>proteolipid</t> protein <t>(PLP)</t> (G) are presented for each frontotemporal lobar dementia case. FTLD, frontotemporal lobar dementia; H-AD, high likelihood Alzheimer’s disease; AT8, phosphorylated tau protein; He, hematoxylin; GM, grey matter; WM, white matter; TDP-43, TAR DNA-binding protein 43; PLP, proteolipid protein. NIIs, intranuclear inclusion; NCIs, neuronal cytoplasmic inclusions; DNs, dystrophic neurites.
Mouse Anti Plp, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proteolipid+protein+plp/Mouse+anti+Myelin+Proteolipid+Protein/pmc12153947-80-99-101
Average 94 stars, based on 1 article reviews
mouse anti plp - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Bio-Rad proteolipid protein plp
Neuropathological findings across study subjects. (A) Staining with AT8 (Tau) across superior and middle temporal samples from each study subject (left panel). (B) Higher magnification AT8 staining (right panel) from representative grey and white matter regions, indicated by squares in the left panel. (C) Immunohistochemical staining with TDP-43 across the preparations from all study subjects (left panel). (D) Corresponding magnification of grey and white matter regions (right panel), indicated by squares in the left panel. (E) Additional magnification and morphological features of TDP-43 aggregates in GM regions from FTLD subjects. Additional whole-section and high magnification images of grey and white matter stained for β-amyloid (F) and <t>proteolipid</t> protein <t>(PLP)</t> (G) are presented for each frontotemporal lobar dementia case. FTLD, frontotemporal lobar dementia; H-AD, high likelihood Alzheimer’s disease; AT8, phosphorylated tau protein; He, hematoxylin; GM, grey matter; WM, white matter; TDP-43, TAR DNA-binding protein 43; PLP, proteolipid protein. NIIs, intranuclear inclusion; NCIs, neuronal cytoplasmic inclusions; DNs, dystrophic neurites.
Proteolipid Protein Plp, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proteolipid+protein+plp/Mouse+anti+Myelin+Proteolipid+Protein/pmc12129743-117-24-28
Average 94 stars, based on 1 article reviews
proteolipid protein plp - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

plp  (Bio-Rad)
94
Bio-Rad plp
Neuropathological findings across study subjects. (A) Staining with AT8 (Tau) across superior and middle temporal samples from each study subject (left panel). (B) Higher magnification AT8 staining (right panel) from representative grey and white matter regions, indicated by squares in the left panel. (C) Immunohistochemical staining with TDP-43 across the preparations from all study subjects (left panel). (D) Corresponding magnification of grey and white matter regions (right panel), indicated by squares in the left panel. (E) Additional magnification and morphological features of TDP-43 aggregates in GM regions from FTLD subjects. Additional whole-section and high magnification images of grey and white matter stained for β-amyloid (F) and <t>proteolipid</t> protein <t>(PLP)</t> (G) are presented for each frontotemporal lobar dementia case. FTLD, frontotemporal lobar dementia; H-AD, high likelihood Alzheimer’s disease; AT8, phosphorylated tau protein; He, hematoxylin; GM, grey matter; WM, white matter; TDP-43, TAR DNA-binding protein 43; PLP, proteolipid protein. NIIs, intranuclear inclusion; NCIs, neuronal cytoplasmic inclusions; DNs, dystrophic neurites.
Plp, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proteolipid+protein+plp/Mouse+anti+Myelin+Proteolipid+Protein/pmc12119693-33-0-10
Average 94 stars, based on 1 article reviews
plp - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

Image Search Results


Neuropathological findings across study subjects. (A) Staining with AT8 (Tau) across superior and middle temporal samples from each study subject (left panel). (B) Higher magnification AT8 staining (right panel) from representative grey and white matter regions, indicated by squares in the left panel. (C) Immunohistochemical staining with TDP-43 across the preparations from all study subjects (left panel). (D) Corresponding magnification of grey and white matter regions (right panel), indicated by squares in the left panel. (E) Additional magnification and morphological features of TDP-43 aggregates in GM regions from FTLD subjects. Additional whole-section and high magnification images of grey and white matter stained for β-amyloid (F) and proteolipid protein (PLP) (G) are presented for each frontotemporal lobar dementia case. FTLD, frontotemporal lobar dementia; H-AD, high likelihood Alzheimer’s disease; AT8, phosphorylated tau protein; He, hematoxylin; GM, grey matter; WM, white matter; TDP-43, TAR DNA-binding protein 43; PLP, proteolipid protein. NIIs, intranuclear inclusion; NCIs, neuronal cytoplasmic inclusions; DNs, dystrophic neurites.

Journal: Frontiers in Neuroscience

Article Title: Fourier transform infrared spectroscopy detects distinct TAR DNA-binding protein 43 signatures in frontotemporal lobar degeneration

doi: 10.3389/fnins.2025.1649433

Figure Lengend Snippet: Neuropathological findings across study subjects. (A) Staining with AT8 (Tau) across superior and middle temporal samples from each study subject (left panel). (B) Higher magnification AT8 staining (right panel) from representative grey and white matter regions, indicated by squares in the left panel. (C) Immunohistochemical staining with TDP-43 across the preparations from all study subjects (left panel). (D) Corresponding magnification of grey and white matter regions (right panel), indicated by squares in the left panel. (E) Additional magnification and morphological features of TDP-43 aggregates in GM regions from FTLD subjects. Additional whole-section and high magnification images of grey and white matter stained for β-amyloid (F) and proteolipid protein (PLP) (G) are presented for each frontotemporal lobar dementia case. FTLD, frontotemporal lobar dementia; H-AD, high likelihood Alzheimer’s disease; AT8, phosphorylated tau protein; He, hematoxylin; GM, grey matter; WM, white matter; TDP-43, TAR DNA-binding protein 43; PLP, proteolipid protein. NIIs, intranuclear inclusion; NCIs, neuronal cytoplasmic inclusions; DNs, dystrophic neurites.

Article Snippet: Myelin proteolipid protein (PLP) staining (Serotec, Oxford, United Kingdom, 1:500) was performed by standard DAB staining procedures as previously described ( ).

Techniques: Staining, Immunohistochemical staining, Binding Assay